Center for Health Technology and Services Research (CINTESIS), Porto, Portugal
Search for other papers by Claudia Matta-Coelho in
Google Scholar
PubMed
Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal
Search for other papers by Joana Simões-Pereira in
Google Scholar
PubMed
Search for other papers by Helena Vilar in
Google Scholar
PubMed
Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
) present with distant disease at diagnosis, and 7–23% develop metastatic disease during follow-up [ 4 ]. These metastases occur mainly in the lungs and bone and decrease the patient’s 10-year survival rate by 50% [ 5 ]. Overall, bone metastases (BM) occur
Search for other papers by M. Schlumberger in
Google Scholar
PubMed
Search for other papers by L. Bastholt in
Google Scholar
PubMed
Search for other papers by H. Dralle in
Google Scholar
PubMed
Search for other papers by B. Jarzab in
Google Scholar
PubMed
Search for other papers by F. Pacini in
Google Scholar
PubMed
Search for other papers by J.W.A. Smit in
Google Scholar
PubMed
(MTC) accounts for less than 5% of all thyroid cancers [ 1 , 5 ]. Distant metastases are observed at presentation in 7–23% of MTC patients [ 1 , 5 ] and can be imaged with standardized protocols [ 6 ]. Symptomatic clinical disease will occur in one to
Institute of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Lars Folkestad in
Google Scholar
PubMed
Search for other papers by Frans Brandt in
Google Scholar
PubMed
Search for other papers by Thomas Brix in
Google Scholar
PubMed
Search for other papers by Marianne Vogsen in
Google Scholar
PubMed
Search for other papers by Lars Bastholt in
Google Scholar
PubMed
Search for other papers by Peter Grupe in
Google Scholar
PubMed
Search for other papers by Jeanette Krogh Petersen in
Google Scholar
PubMed
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
[ 11 - 14 ]. Theoretically, TRAB, due to stimulation of thyroid tissue, could not only induce thyroid malignancy but also make a tumor and/or distant metastases develop more aggressively. Patients diagnosed with GD within a short period of time after
Search for other papers by Daniela Cavaco in
Google Scholar
PubMed
Search for other papers by Sara Carvalhal in
Google Scholar
PubMed
NOVA Medical School
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
life. Metastatic papillary thyroid carcinoma (PTC) with cutaneous metastases may cause pain, ulceration, and bleeding. Novel Insights ECT seems to be a safe and effective technique and may be an option for local palliative
Search for other papers by Ana Piñar-Gutiérrez in
Google Scholar
PubMed
Search for other papers by Ana R Romero-Lluch in
Google Scholar
PubMed
Search for other papers by Suset Dueñas-Disotuar in
Google Scholar
PubMed
Search for other papers by Irene de Lara-Rodríguez in
Google Scholar
PubMed
Search for other papers by María Ángeles Gálvez-Moreno in
Google Scholar
PubMed
Search for other papers by Tomás Martín-Hernández in
Google Scholar
PubMed
Search for other papers by Jorge García-Alemán in
Google Scholar
PubMed
Search for other papers by Guillermo Martínez-de Pinillos in
Google Scholar
PubMed
Search for other papers by Elena Navarro-González in
Google Scholar
PubMed
Introduction Bone metastases (BMs) are infrequent in differentiated thyroid carcinoma (DTC), occurring in 2–13% of the cases. It has been estimated that BMs occur in 7–28% of follicular carcinomas and 1.4–7% of papillary carcinomas, although
Search for other papers by Luciana Puleo in
Google Scholar
PubMed
Search for other papers by Laura Agate in
Google Scholar
PubMed
Search for other papers by Irene Bargellini in
Google Scholar
PubMed
Search for other papers by Giuseppe Boni in
Google Scholar
PubMed
Search for other papers by Paolo Piaggi in
Google Scholar
PubMed
Search for other papers by Claudio Traino in
Google Scholar
PubMed
Search for other papers by Tommaso Depalo in
Google Scholar
PubMed
Search for other papers by Giulia Lorenzoni in
Google Scholar
PubMed
Search for other papers by Francesca Bianchi in
Google Scholar
PubMed
Search for other papers by Duccio Volterrani in
Google Scholar
PubMed
Search for other papers by Sandra Brogioni in
Google Scholar
PubMed
Search for other papers by Valeria Bottici in
Google Scholar
PubMed
Search for other papers by Maurizia Rossana Brunetto in
Google Scholar
PubMed
Search for other papers by Barbara Coco in
Google Scholar
PubMed
Search for other papers by Eleonora Molinaro in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
be achieved in those MTC with an early diagnosis and treatment ( 1 , 2 , 3 ). Nevertheless, about 10% of patients have distant metastases at diagnosis and this is the subgroup with the worst prognosis ( 4 ). According to the American Thyroid
Search for other papers by Filipe Pereira in
Google Scholar
PubMed
Instituto de Investigação e Inovação em Saúde (I3S), Universidade do Porto
Search for other papers by Sofia S. Pereira in
Google Scholar
PubMed
Search for other papers by Marta Mesquita in
Google Scholar
PubMed
Search for other papers by Tiago Morais in
Google Scholar
PubMed
Search for other papers by Madalena M. Costa in
Google Scholar
PubMed
Instituto de Engenharia Biomédica (INEB), Universidade do Porto, Porto
Search for other papers by Pedro Quelhas in
Google Scholar
PubMed
Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto
Search for other papers by Carlos Lopes in
Google Scholar
PubMed
Search for other papers by Mariana P. Monteiro in
Google Scholar
PubMed
Serviço de Endocrinologia, Instituto Português de Oncologia de Lisboa, Francisco Gentil, Lisbon, Portugal
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
metastases has been found to correlate with intratumoral but not with peritumoral LVD [ 11 ]. Except for Eloy et al. [ 13 ], all studies were hampered by the fact that PTCs with different metastization patterns, such as the classical and follicular variants
Search for other papers by Francesca Orsolini in
Google Scholar
PubMed
Search for other papers by Alessandro Prete in
Google Scholar
PubMed
Search for other papers by Pierpaolo Falcetta in
Google Scholar
PubMed
Search for other papers by Domenico Canale in
Google Scholar
PubMed
Search for other papers by Fulvio Basolo in
Google Scholar
PubMed
Search for other papers by Greta Alì in
Google Scholar
PubMed
Search for other papers by Francesca Manassero in
Google Scholar
PubMed
Search for other papers by Paolo Vitti in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Search for other papers by Eleonora Molinaro in
Google Scholar
PubMed
). In 30–50% of the cases, MTC is accompanied by metastases in cervical and/or paratracheal lymph nodes, and the tumor spreads also to the upper and anterior mediastinal lymph nodes. Distant metastases are present at the diagnosis in 10–15% of patients
Department of Medicine, Endocrinology Service, Hospital Universitário Clementino Fraga Filho, Rio de Janeiro, Brazil
Search for other papers by Fernanda Andrade in
Google Scholar
PubMed
Search for other papers by Danielle Probstner in
Google Scholar
PubMed
Search for other papers by Marcus Decnop in
Google Scholar
PubMed
Search for other papers by Daniel Bulzico in
Google Scholar
PubMed
Search for other papers by Denise Momesso in
Google Scholar
PubMed
Department of Medicine, Endocrinology Service, Hospital Universitário Clementino Fraga Filho, Rio de Janeiro, Brazil
Search for other papers by Rossana Corbo in
Google Scholar
PubMed
Search for other papers by Mario Vaisman in
Google Scholar
PubMed
Department of Medicine, Endocrinology Service, Hospital Universitário Clementino Fraga Filho, Rio de Janeiro, Brazil
Search for other papers by Fernanda Vaisman in
Google Scholar
PubMed
be affected in up to 70–90% of cases [ 2 , 3 ]. Among differentiated thyroid cancer (DTC), it is the second most frequent site of distant metastases. Incidence may vary from 2 to 13% [ 4 ], influenced by the degree of differentiation and histologic
Search for other papers by Laura Agate in
Google Scholar
PubMed
Search for other papers by Francesca Bianchi in
Google Scholar
PubMed
Search for other papers by Federica Brozzi in
Google Scholar
PubMed
Search for other papers by Pierina Santini in
Google Scholar
PubMed
Search for other papers by Eleonora Molinaro in
Google Scholar
PubMed
Search for other papers by Valeria Bottici in
Google Scholar
PubMed
Search for other papers by David Viola in
Google Scholar
PubMed
Search for other papers by Loredana Lorusso in
Google Scholar
PubMed
Search for other papers by Paolo Vitti in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
supraclavear node compartments were evaluated for the presence of suspicious disease recurrence or persistence. In suspicious lymph node metastases, a fine-needle aspiration biopsy with Tg measurement in the needle washout was performed. 131 I